gabexate has been researched along with Disseminated Intravascular Coagulation in 86 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Disseminated Intravascular Coagulation: A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We hypothesized that antithrombin is more effective for disseminated intravascular coagulation (DIC) than is gabexate mesilate, which is a protease inhibitor, suggested from the previous studies." | 9.16 | Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study. ( Kohno, Y; Koishi, K; Nishiyama, T, 2012) |
| "Gabexate mesilate (GM) is a promising anticoagulation treatment for disseminated intravascular coagulation (DIC)." | 9.11 | Efficacy of gabexate mesilate on disseminated intravascular coagulation as a complication of infection developing after abdominal surgery. ( Chen, HM; Chen, JC; Chen, MF; Chiu, DF; Hsu, JT; Huang, CJ; Hwang, TL; Jan, YY, 2004) |
| "The effects of gabexate mesilate on disseminated intravascular coagulation (DIC) accompanying neoplastic diseases or severe infections in ten patients were investigated and compared with those of heparin therapy in ten other patients with DIC." | 9.06 | Gabexate as a therapy for disseminated intravascular coagulation. ( Adachi, M; Soejima, R; Umeki, S; Watanabe, M; Yaji, S, 1988) |
| "We evaluated clinical outcomes of disseminated intravascular coagulation (DIC) in patients with hematological malignancies treated with synthetic protease inhibitors (SPIs) and compared the effects of gabexate mesilate (FOY) and nafamostat mesilate (FUT)." | 7.91 | Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies. ( Ashizawa, M; Fujiwara, SI; Hatano, K; Ikeda, T; Ito, S; Kanda, Y; Kawaguchi, SI; Kawasaki, Y; Mashima, K; Minakata, D; Morita, K; Muroi, K; Nagayama, T; Nakano, H; Ochi, SI; Oh, I; Ohmine, K; Ohmori, T; Sato, K; Sugimoto, M; Toda, Y; Umino, K; Yamamoto, C; Yamasaki, R, 2019) |
| " We retrospectively evaluated and compared the efficacies of rhTM and gabexate mesilate (GM) in patients diagnosed with sepsis-induced DIC." | 7.80 | A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients. ( Imamura, Y; Izumikawa, K; Kohno, S; Matsuo, N; Miyazaki, T; Nakamura, S; Sawai, T; Suyama, N; Takazono, T; Yanagihara, K; Yoshioka, S, 2014) |
| "25 mg/kg/hr for 4 hr) was shown to induce disseminated intravascular coagulation (DIC) in rats, which resulted in hypofibrinogenemia, prolongation of prothrombin (PT) and partial thromboplastin time (PTT), thrombocytopenia, and elevated levels of fibrinogen/fibrin degradation products (FDP)." | 7.68 | Effect of a selective PAF antagonist SM-10661 ((+/-)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one HCl) on experimental disseminated intravascular coagulation (DIC). ( Imanishi, N; Komuro, Y; Morooka, S, 1991) |
| "We describe a case of thoracic aortic aneurysm complicated by chronic disseminated intravascular coagulation (DIC)." | 5.31 | [Thoracic aortic aneurysm with chronic disseminated intravascular coagulation treated successfully with orally administered camostat mesilate, warfarin and aspirin]. ( Fukuda, N; Nakamori, Y; Oeda, E; Sato, Y; Shimohakamada, Y; Shinohara, K; Takahashi, T; Tominaga, T, 2002) |
| "He was diagnosed as having chronic disseminated intravascular coagulation (DIC) complicated by a thoracoabdominal aortic aneurysm, and was treated with heparin sodium and a protease inhibitor." | 5.31 | [Effective use of camostat mesilate for chronic disseminated intravascular coagulation complicated by thoracoabdominal aortic aneurysm]. ( Amano, I; Morii, T; Narita, N; Tanaka, H; Tsukaguchi, N; Yagi, H; Yoneda, K, 2001) |
| "We investigated FOY therapy for the treatment of disseminated intravascular coagulation (DIC) associated with sepsis in 15 patients (group F), and compared it with heparin therapy in 8 patients (group H)." | 5.27 | Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis. ( Hirata, T; Kambayashi, J; Nishijima, MK; Shimada, Y; Taenaka, N; Takezawa, J; Yoshiya, I, 1983) |
| "Experimental disseminated intravascular coagulation (DIC) can be induced by 4 h sustained infusion of endotoxin at a dose of 100 mg/kg in rats." | 5.27 | Protective effect of gabexate mesilate against experimental disseminated intravascular coagulation in rats. ( Furukawa, Y; Kondo, M; Murakami, M; Takemura, S; Yoshikawa, T, 1983) |
| "Gabexate mesilate was more likely to attenuate neutrophil-mediated oxidative stress on microvasculature in endotoxin-induced DIC than heparin sodium." | 5.27 | Microcirculatory disturbances in endotoxin-induced disseminated intravascular coagulation. The effects of heparin and gabexate mesilate on locomotive and metabolic changes of neutrophils. ( Miura, S; Oda, M; Oshio, C; Suematsu, M; Suzuki, M; Tsuchiya, M, 1988) |
| "We hypothesized that antithrombin is more effective for disseminated intravascular coagulation (DIC) than is gabexate mesilate, which is a protease inhibitor, suggested from the previous studies." | 5.16 | Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study. ( Kohno, Y; Koishi, K; Nishiyama, T, 2012) |
| "Gabexate mesilate (GM) is a promising anticoagulation treatment for disseminated intravascular coagulation (DIC)." | 5.11 | Efficacy of gabexate mesilate on disseminated intravascular coagulation as a complication of infection developing after abdominal surgery. ( Chen, HM; Chen, JC; Chen, MF; Chiu, DF; Hsu, JT; Huang, CJ; Hwang, TL; Jan, YY, 2004) |
| "To investigate the effect of a protease inhibitor, gabexate mesylate, on patients with pre- or mild disseminated intravascular coagulation (DIC) in comparison with a control group receiving no anticoagulation therapy." | 5.09 | Is protease inhibitor a choice for the treatment of pre- or mild disseminated intravascular coagulation? ( Hanaoka, K; Matsukawa, T; Nishiyama, T, 2000) |
| "The effects of gabexate mesilate on disseminated intravascular coagulation (DIC) accompanying neoplastic diseases or severe infections in ten patients were investigated and compared with those of heparin therapy in ten other patients with DIC." | 5.06 | Gabexate as a therapy for disseminated intravascular coagulation. ( Adachi, M; Soejima, R; Umeki, S; Watanabe, M; Yaji, S, 1988) |
| "We evaluated clinical outcomes of disseminated intravascular coagulation (DIC) in patients with hematological malignancies treated with synthetic protease inhibitors (SPIs) and compared the effects of gabexate mesilate (FOY) and nafamostat mesilate (FUT)." | 3.91 | Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies. ( Ashizawa, M; Fujiwara, SI; Hatano, K; Ikeda, T; Ito, S; Kanda, Y; Kawaguchi, SI; Kawasaki, Y; Mashima, K; Minakata, D; Morita, K; Muroi, K; Nagayama, T; Nakano, H; Ochi, SI; Oh, I; Ohmine, K; Ohmori, T; Sato, K; Sugimoto, M; Toda, Y; Umino, K; Yamamoto, C; Yamasaki, R, 2019) |
| "Efficacy of recombinant human soluble thrombomodulin (rhTM), which is frequently used to treat patients with disseminated intravascular coagulation (DIC), was compared with that of gabexate mesilate (GM), which was previously used routinely in the treatment of DIC patients in Japan." | 3.83 | The efficacy of the administration of recombinant human soluble thrombomodulin in patients with DIC. ( Aota, T; Imai, H; Isaji, S; Katayama, N; Matsumoto, T; Ohishi, K; Suzuki, K; Usui, M; Wada, H; Yamashita, Y, 2016) |
| " We retrospectively evaluated and compared the efficacies of rhTM and gabexate mesilate (GM) in patients diagnosed with sepsis-induced DIC." | 3.80 | A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients. ( Imamura, Y; Izumikawa, K; Kohno, S; Matsuo, N; Miyazaki, T; Nakamura, S; Sawai, T; Suyama, N; Takazono, T; Yanagihara, K; Yoshioka, S, 2014) |
| "25 mg/kg/hr for 4 hr) was shown to induce disseminated intravascular coagulation (DIC) in rats, which resulted in hypofibrinogenemia, prolongation of prothrombin (PT) and partial thromboplastin time (PTT), thrombocytopenia, and elevated levels of fibrinogen/fibrin degradation products (FDP)." | 3.68 | Effect of a selective PAF antagonist SM-10661 ((+/-)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one HCl) on experimental disseminated intravascular coagulation (DIC). ( Imanishi, N; Komuro, Y; Morooka, S, 1991) |
| "Sequential therapy consisting of methotrexate (MTX) and 5-FU was performed together with the administration of heparin and FOY in 10 cases of gastric cancer with disseminated intravascular coagulation (DIC) causing systemic bone metastasis." | 3.68 | [Sequential MTX and 5-FU therapy of gastric cancer with systemic bone metastasis and disseminated intravascular coagulation]. ( Ibuka, T; Imai, K; Ishiwata, J; Kobayashi, T; Monma, K; Ohno, T; Onozawa, Y; Sakaki, N; Sasaki, T; Tabata, I, 1992) |
| " MD-805 was also administered to ten patients with disseminated intravascular coagulation (DIC), eight of whom had not responded to either heparin or gabexate mesilate (FOY), and eight of whom had circulating antithrombin III levels below 20 mg/dl." | 3.67 | Anticoagulation with a synthetic thrombin inhibitor after cardiovascular surgery and for treatment of disseminated intravascular coagulation. ( Fujita, T; Kumon, K; Naito, Y; Nakajima, N; Tanaka, K, 1984) |
| "One hundred and ninety-one patients with disseminated intravascular coagulation syndrome (DIC) or its prodromal stage (preDIC) were treated with only gabaxate mesilate (FOY) (group G) or a combination of gabaxate and unfractionated heparin (group GH), and the efficacy of gabaxate was evaluated in a multicenter study." | 2.67 | Treatment of disseminated intravascular coagulation and its prodromal stage with gabaxate mesilate (FOY): a multi-center trial. ( Chiba, S; Hara, K; Ichimaru, M; Itoga, T; Kotsuru, M; Miyake, M; Niho, Y; Okamura, T; Saito, H; Takatsuki, K, 1993) |
| "Whereas in DIC associated with trauma, since balance between coagulation and fibrinolysis collapses drastically in a short period, both anticoagulantion therapy and antifibrinolytic therapy can be utilized depending on clinical conditions." | 2.53 | [Anti DIC therapy]. ( Sakamoto, Y; Yahata, M, 2016) |
| "A case of disseminated intravascular coagulation (DIC) in a patient with systemic lupus erythematosus (SLE) with acute liver dysfunction is described." | 2.38 | Disseminated intravascular coagulation in lupus erythematosus with acute liver damage. ( Kaneda, S; Sano, M; Shimamoto, Y; Tsunada, S; Yamaguchi, M; Yamamoto, K, 1992) |
| "Thyroid storm is a rare disorder with a sudden onset, rapid progression and high mortality." | 1.38 | Thyroid storm with multiple organ failure, disseminated intravascular coagulation, and stroke with a normal serum FT3 level. ( Akiyama, H; Handa, M; Harada, Y; Ryuzaki, M; Urao, Y; Yoshimoto, T, 2012) |
| "A 64-year-old man was diagnosed with acute myeloid leukemia (AML) complicated by disseminated intravascular coagulation." | 1.35 | Leukemia cutis originating in the extravasation site of i.v. gabexate mesilate infusion. ( Aota, Y; Iguchi, T; Kurashige, Y; Miyakura, T; Nagai, A; Tsuboi, R; Yamamoto, T, 2008) |
| "The case was complicated with disseminated intravascular coagulation." | 1.32 | [A case of severe Chlamydia pneumoniae pneumonia requiring mechanical ventilation and complicated with disseminated intravascular coagulation]. ( Arimura, Y; Ashitani, J; Kato, S; Sano, A; Yanagi, S, 2003) |
| "He was diagnosed as having chronic disseminated intravascular coagulation (DIC) complicated by a thoracoabdominal aortic aneurysm, and was treated with heparin sodium and a protease inhibitor." | 1.31 | [Effective use of camostat mesilate for chronic disseminated intravascular coagulation complicated by thoracoabdominal aortic aneurysm]. ( Amano, I; Morii, T; Narita, N; Tanaka, H; Tsukaguchi, N; Yagi, H; Yoneda, K, 2001) |
| "We describe a case of thoracic aortic aneurysm complicated by chronic disseminated intravascular coagulation (DIC)." | 1.31 | [Thoracic aortic aneurysm with chronic disseminated intravascular coagulation treated successfully with orally administered camostat mesilate, warfarin and aspirin]. ( Fukuda, N; Nakamori, Y; Oeda, E; Sato, Y; Shimohakamada, Y; Shinohara, K; Takahashi, T; Tominaga, T, 2002) |
| "Pyogenic osteomyelitis is often accompanied by diabetes, but the disease in the clavicula has rarely been reported." | 1.30 | Pyogenic clavicular osteomyelitis associated with disseminated intravascular coagulation and acute renal failure in a patient with non-insulin-dependent diabetes mellitus. ( Kasamatsu, Y; Kondo, M; Nagata, H; Nakamura, Y; Yokoo, S; Yoshida, T; Yoshioka, K, 1997) |
| "The status epilepticus was also attenuated by the use of thiamylal sodium." | 1.30 | [A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation]. ( Miyoshi, T; Motomura, S; Osoegawa, M; Tamura, K; Yamanaka, H, 1999) |
| "He was diagnosed as metastatic bone cancer with disseminated intravascular coagulation (DIC)." | 1.28 | Disseminated carcinomatosis of bone marrow from submucosal carcinoma in adenoma of the rectum. ( Andachi, H; Shimizu, H; Yokoo, S; Yoshioka, K, 1992) |
| "The occurrence of disseminated intravascular coagulation (DIC) is not rare in neurosurgical patients." | 1.28 | [Diagnosis and treatment of disseminated intravascular coagulation associated with neurosurgical diseases; a proposal of a new scoring system for DIC]. ( Fujii, Y; Kameyama, S; Koike, T; Takahashi, H; Tanaka, R, 1992) |
| "To investigate disseminated intravascular coagulation (DIC) after valve replacement, we studied DIC score in 80 patients with combined cardiac valvular disease." | 1.28 | [Disseminated intravascular coagulation (DIC) after artificial valve replacement: especially tricuspid regurgitation]. ( Abe, T; Hagiwara, K; Igari, T; Iwaya, F; Midorikawa, H; Sato, Y; Satokawa, H; Takase, S; Tanji, M; Watanabe, M, 1990) |
| "Experimental disseminated intravascular coagulation (DIC) can be induced by 4 h sustained infusion of endotoxin at a dose of 100 mg/kg in rats." | 1.27 | Protective effect of gabexate mesilate against experimental disseminated intravascular coagulation in rats. ( Furukawa, Y; Kondo, M; Murakami, M; Takemura, S; Yoshikawa, T, 1983) |
| "We investigated FOY therapy for the treatment of disseminated intravascular coagulation (DIC) associated with sepsis in 15 patients (group F), and compared it with heparin therapy in 8 patients (group H)." | 1.27 | Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis. ( Hirata, T; Kambayashi, J; Nishijima, MK; Shimada, Y; Taenaka, N; Takezawa, J; Yoshiya, I, 1983) |
| "Gabexate mesilate was more likely to attenuate neutrophil-mediated oxidative stress on microvasculature in endotoxin-induced DIC than heparin sodium." | 1.27 | Microcirculatory disturbances in endotoxin-induced disseminated intravascular coagulation. The effects of heparin and gabexate mesilate on locomotive and metabolic changes of neutrophils. ( Miura, S; Oda, M; Oshio, C; Suematsu, M; Suzuki, M; Tsuchiya, M, 1988) |
| "These changes included acute disseminated intravascular coagulation, severe elevations of liver enzymes, severe renal dysfunction, and hemolytic anemia." | 1.27 | A case of postpartum hemolytic uremic syndrome with severe elevations of liver enzymes. ( Fujii, S; Kanzaki, H; Kariya, M; Matsuura, S; Mori, T; Sagawa, N, 1985) |
| "Coagulation studies revealed disseminated intravascular coagulation and a diagnosis of amniotic fluid embolism was made." | 1.26 | Survival from DIC following amniotic fluid embolism. Successful treatment with a serine proteinase inhibitor; FOY. ( Kawai, M; Kosaki, G; Shimada, Y; Taenaka, N; Yoshiya, I, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (34.88) | 18.7374 |
| 1990's | 30 (34.88) | 18.2507 |
| 2000's | 12 (13.95) | 29.6817 |
| 2010's | 14 (16.28) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ookura, M | 1 |
| Hosono, N | 1 |
| Tasaki, T | 1 |
| Oiwa, K | 1 |
| Fujita, K | 1 |
| Ito, K | 1 |
| Lee, S | 1 |
| Matsuda, Y | 1 |
| Morita, M | 2 |
| Tai, K | 1 |
| Negoro, E | 1 |
| Kishi, S | 1 |
| Iwasaki, H | 1 |
| Ueda, T | 1 |
| Yamauchi, T | 1 |
| Minakata, D | 1 |
| Fujiwara, SI | 1 |
| Ikeda, T | 2 |
| Kawaguchi, SI | 1 |
| Toda, Y | 1 |
| Ito, S | 1 |
| Ochi, SI | 1 |
| Nagayama, T | 1 |
| Mashima, K | 1 |
| Umino, K | 1 |
| Nakano, H | 1 |
| Yamasaki, R | 1 |
| Morita, K | 1 |
| Kawasaki, Y | 1 |
| Sugimoto, M | 1 |
| Yamamoto, C | 1 |
| Ashizawa, M | 1 |
| Hatano, K | 1 |
| Sato, K | 1 |
| Oh, I | 1 |
| Ohmine, K | 1 |
| Muroi, K | 1 |
| Ohmori, T | 1 |
| Kanda, Y | 1 |
| Hashimoto, D | 1 |
| Okawa, T | 1 |
| Maruyama, R | 1 |
| Matsumura, F | 1 |
| Shibata, Y | 1 |
| Kohrogi, H | 1 |
| Gando, S | 2 |
| Saitoh, D | 1 |
| Ishikura, H | 1 |
| Ueyama, M | 1 |
| Otomo, Y | 1 |
| Oda, S | 1 |
| Kushimoto, S | 1 |
| Tanjoh, K | 1 |
| Mayumi, T | 1 |
| Iba, T | 1 |
| Eguchi, Y | 1 |
| Okamoto, K | 2 |
| Ogura, H | 1 |
| Koseki, K | 1 |
| Sakamoto, Y | 2 |
| Takayama, Y | 1 |
| Shirai, K | 1 |
| Takasu, O | 1 |
| Inoue, Y | 1 |
| Mashiko, K | 1 |
| Tsubota, T | 1 |
| Endo, S | 1 |
| Wada, H | 5 |
| Matsumoto, T | 2 |
| Yamashita, Y | 2 |
| Takazono, T | 1 |
| Nakamura, S | 1 |
| Imamura, Y | 1 |
| Yoshioka, S | 1 |
| Miyazaki, T | 1 |
| Izumikawa, K | 1 |
| Sawai, T | 1 |
| Matsuo, N | 1 |
| Yanagihara, K | 1 |
| Suyama, N | 1 |
| Kohno, S | 1 |
| Akahoshi, T | 1 |
| Sugimori, H | 1 |
| Kaku, N | 1 |
| Tokuda, K | 1 |
| Nagata, T | 1 |
| Noda, E | 1 |
| Hashizume, M | 1 |
| Maehara, Y | 1 |
| Aota, T | 1 |
| Ohishi, K | 1 |
| Suzuki, K | 2 |
| Imai, H | 1 |
| Usui, M | 1 |
| Isaji, S | 1 |
| Katayama, N | 1 |
| Yahata, M | 1 |
| Sakata, Y | 1 |
| Koyama, T | 2 |
| Kumura, T | 1 |
| Aoyama, Y | 1 |
| Ichihara, H | 1 |
| Koh, S | 1 |
| Mugitani, A | 1 |
| Hayakawa, H | 1 |
| Yukioka, K | 1 |
| Kinoshita, D | 1 |
| Nakagawa, M | 1 |
| Yamazaki, N | 1 |
| Takahashi, H | 3 |
| Nishiyama, T | 2 |
| Kohno, Y | 1 |
| Koishi, K | 1 |
| Harada, Y | 1 |
| Akiyama, H | 1 |
| Yoshimoto, T | 1 |
| Urao, Y | 1 |
| Ryuzaki, M | 1 |
| Handa, M | 1 |
| Sakakura, M | 1 |
| Saito, T | 1 |
| Tsuchiya, M | 2 |
| Shikata, C | 1 |
| Yamaguchi, H | 1 |
| Miyata, S | 1 |
| Matsuo, S | 1 |
| Ishizawa, S | 1 |
| Yoshimura, K | 1 |
| Yanagi, S | 1 |
| Ashitani, J | 1 |
| Arimura, Y | 1 |
| Sano, A | 1 |
| Kato, S | 1 |
| Hsu, JT | 1 |
| Chen, HM | 1 |
| Chiu, DF | 1 |
| Chen, JC | 1 |
| Huang, CJ | 1 |
| Hwang, TL | 1 |
| Jan, YY | 1 |
| Chen, MF | 1 |
| Miyakura, T | 1 |
| Yamamoto, T | 1 |
| Kurashige, Y | 1 |
| Nagai, A | 1 |
| Iguchi, T | 1 |
| Aota, Y | 1 |
| Tsuboi, R | 1 |
| Kosaki, G | 3 |
| Kambayashi, J | 3 |
| Imaoka, S | 1 |
| Taenaka, N | 2 |
| Shimada, Y | 2 |
| Hirata, T | 1 |
| Nishijima, MK | 1 |
| Takezawa, J | 1 |
| Yoshiya, I | 2 |
| Yoshikawa, T | 3 |
| Furukawa, Y | 3 |
| Murakami, M | 2 |
| Takemura, S | 2 |
| Kondo, M | 4 |
| Maki, M | 3 |
| Soga, K | 1 |
| Gotoh, K | 1 |
| Kojima, M | 1 |
| Shimamura, K | 1 |
| Mori, N | 1 |
| Oka, K | 1 |
| Nakazawa, M | 1 |
| Tamakuma, S | 1 |
| Ogawa, Y | 1 |
| Saito, A | 1 |
| Tsukawaki, Y | 1 |
| Nioka, S | 1 |
| Yoda, K | 1 |
| Miyazaki, M | 1 |
| Kusaka, Y | 1 |
| Ban, S | 1 |
| Chihara, K | 1 |
| Akiyama, F | 1 |
| Shinozaki, T | 1 |
| Shimamoto, M | 1 |
| Takahashi, K | 1 |
| Imura, H | 1 |
| Yamazaki, F | 1 |
| Kawarazaki, S | 1 |
| Kumon, K | 1 |
| Tanaka, K | 1 |
| Nakajima, N | 1 |
| Naito, Y | 1 |
| Fujita, T | 1 |
| Kawai, M | 1 |
| Iwasa, K | 1 |
| Izumi, R | 1 |
| Shimizu, K | 1 |
| Li, T | 1 |
| Masutani, H | 1 |
| Lyobe, T | 1 |
| Fukushima, W | 1 |
| Sakamoto, K | 1 |
| Inoue, T | 1 |
| Muraoka, K | 1 |
| Okamura, T | 2 |
| Niho, Y | 2 |
| Itoga, T | 1 |
| Chiba, S | 1 |
| Miyake, M | 1 |
| Kotsuru, M | 1 |
| Saito, H | 3 |
| Ichimaru, M | 1 |
| Hara, K | 1 |
| Takatsuki, K | 1 |
| Iwabuchi, S | 1 |
| Takatori, M | 1 |
| Okabe, K | 1 |
| Aramoto, H | 1 |
| Shigematsu, H | 1 |
| Muto, T | 1 |
| Yawata, Y | 1 |
| Okuda, T | 1 |
| Yumoto, Y | 1 |
| Ukai, K | 1 |
| Fuji, A | 1 |
| Nishiwaki, J | 1 |
| Yamada, T | 1 |
| Hotta, N | 1 |
| Kobayashi, Y | 1 |
| Kondo, C | 1 |
| Miyajima, K | 1 |
| Takada, T | 1 |
| Kinoshita, Y | 1 |
| Hanai, S | 1 |
| Yuasa, T | 1 |
| Taniguchi, Y | 1 |
| Yamada, E | 1 |
| Inachi, S | 1 |
| Shimizu, M | 1 |
| Yoshioka, K | 2 |
| Nagata, H | 1 |
| Nakamura, Y | 2 |
| Kasamatsu, Y | 1 |
| Yokoo, S | 2 |
| Yoshida, T | 1 |
| Terasako, K | 1 |
| Shinohara, T | 1 |
| Hidaka, T | 1 |
| Matsuki, Y | 1 |
| Ohsuzu, F | 1 |
| Osoegawa, M | 1 |
| Motomura, S | 1 |
| Yamanaka, H | 1 |
| Tamura, K | 1 |
| Miyoshi, T | 1 |
| Matsukawa, T | 1 |
| Hanaoka, K | 1 |
| Ita, M | 1 |
| Okafuji, M | 1 |
| Maruoka, Y | 1 |
| Shinozaki, F | 1 |
| Yoneda, K | 1 |
| Amano, I | 1 |
| Tanaka, H | 2 |
| Yagi, H | 1 |
| Tsukaguchi, N | 1 |
| Morii, T | 1 |
| Narita, N | 1 |
| Yokota, T | 1 |
| Yamada, Y | 1 |
| Takahashi, M | 1 |
| Kunii, Y | 1 |
| Iwamoto, K | 1 |
| Kagami, M | 1 |
| Kikuchi, S | 1 |
| Yamauchi, H | 1 |
| Yoshikawa, K | 1 |
| Fukuda, N | 1 |
| Shimohakamada, Y | 1 |
| Nakamori, Y | 1 |
| Tominaga, T | 1 |
| Shinohara, K | 1 |
| Takahashi, T | 1 |
| Oeda, E | 1 |
| Sato, Y | 2 |
| Kashima, K | 1 |
| Kataoka, K | 1 |
| Umehara, K | 1 |
| Shimamoto, Y | 1 |
| Sano, M | 1 |
| Kaneda, S | 1 |
| Tsunada, S | 1 |
| Yamamoto, K | 1 |
| Yamaguchi, M | 1 |
| Kobayashi, T | 1 |
| Sasaki, T | 1 |
| Ibuka, T | 1 |
| Imai, K | 1 |
| Monma, K | 1 |
| Sakaki, N | 1 |
| Tabata, I | 1 |
| Ishiwata, J | 1 |
| Onozawa, Y | 1 |
| Ohno, T | 1 |
| Shimizu, H | 1 |
| Andachi, H | 1 |
| Murakawa, M | 1 |
| Shibuya, T | 1 |
| Harada, M | 1 |
| Otsuka, T | 1 |
| Kameyama, S | 1 |
| Fujii, Y | 1 |
| Koike, T | 1 |
| Tanaka, R | 1 |
| Kazama, M | 1 |
| Kobayashi, K | 1 |
| Tahara, C | 1 |
| Miyajima, Y | 1 |
| Endo, Y | 1 |
| Nakatani, T | 1 |
| Tajimi, K | 1 |
| Yoshida, K | 2 |
| Toki, F | 1 |
| Takeuchi, T | 1 |
| Motoki, R | 1 |
| Inoue, H | 1 |
| Imanishi, N | 1 |
| Komuro, Y | 1 |
| Morooka, S | 1 |
| Kobayashi, N | 1 |
| Yasunaga, M | 1 |
| Mori, K | 2 |
| Yamashita, S | 1 |
| Okita, K | 1 |
| Takeda, S | 2 |
| Ohsato, K | 1 |
| Satokawa, H | 1 |
| Iwaya, F | 1 |
| Igari, T | 1 |
| Abe, T | 1 |
| Hagiwara, K | 1 |
| Tanji, M | 1 |
| Watanabe, M | 2 |
| Midorikawa, H | 1 |
| Takase, S | 1 |
| Wakui, K | 1 |
| Takemae, T | 1 |
| Kobayashi, S | 1 |
| Tsuzuki, T | 1 |
| Toyama, K | 1 |
| Nakayasu, K | 1 |
| Iida, S | 1 |
| Ueda, M | 1 |
| Toizumi, A | 1 |
| Murata, M | 1 |
| Hayakawa, M | 1 |
| Goto, K | 1 |
| Isobe, K | 1 |
| Matuura, T | 1 |
| Hirano, H | 1 |
| Higuchi, M | 1 |
| Toyoda, O | 1 |
| Nojiri, K | 1 |
| Nakajima, H | 1 |
| Takemoto, Y | 1 |
| Tanaka, S | 1 |
| Tanabe, J | 1 |
| Kohama, A | 1 |
| Shibata, S | 1 |
| Terada, H | 1 |
| Suzuki, H | 3 |
| Deguchi, A | 2 |
| Mori, Y | 2 |
| Okubo, I | 1 |
| Tsuda, M | 2 |
| Nagano, T | 1 |
| Deguchi, K | 2 |
| Shirakawa, S | 2 |
| Yajima, Y | 1 |
| Otsuki, M | 1 |
| Goto, Y | 1 |
| Terao, T | 1 |
| Ikenoue, T | 1 |
| Takemura, T | 1 |
| Sekiba, K | 1 |
| Shirakawa, K | 1 |
| Soma, H | 1 |
| Mukaiyama, H | 1 |
| Shionoya, S | 1 |
| Ikezawa, T | 1 |
| Kamiya, T | 1 |
| Hamaguchi, M | 1 |
| Kume, M | 1 |
| Takechi, K | 1 |
| Kasamatsu, T | 1 |
| Kinoshita, K | 1 |
| Mizuno, M | 1 |
| Sakamoto, S | 1 |
| Umeki, S | 1 |
| Adachi, M | 1 |
| Yaji, S | 1 |
| Soejima, R | 1 |
| Oukubo, I | 1 |
| Tanaka, I | 1 |
| Minami, N | 1 |
| Taniguchi, N | 1 |
| Kitani, T | 1 |
| Kawagoe, H | 1 |
| Horiuchi, A | 1 |
| Masaoka, T | 1 |
| Yasunaga, K | 1 |
| Okamoto, Y | 1 |
| Ohkubo, A | 1 |
| Yonezawa, T | 1 |
| Nagai, K | 1 |
| Suzuki, M | 1 |
| Suematsu, M | 1 |
| Miura, S | 1 |
| Oshio, C | 1 |
| Oda, M | 1 |
| Tedo, I | 1 |
| Sagawa, N | 1 |
| Kariya, M | 1 |
| Kanzaki, H | 1 |
| Fujii, S | 1 |
| Matsuura, S | 1 |
| Mori, T | 1 |
| Ishikawa, H | 1 |
| Ishikawa, S | 1 |
| Rinsho, K | 1 |
| Yazaki, T | 1 |
| Kanoh, S | 1 |
| Koiso, K | 1 |
| Uchida, K | 1 |
| Iizumi, T | 1 |
| Takeshima, H | 1 |
| Umeyama, T | 1 |
| Kato, H | 1 |
| Sugino, S | 1 |
| Yamada, K | 1 |
| Matsuda, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| RAndomized Clinical Trial in COvid19 Patients to Assess the Efficacy of the Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor NAfamostat (RACONA Study)[NCT04352400] | Phase 2/Phase 3 | 256 participants (Anticipated) | Interventional | 2021-06-04 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
17 reviews available for gabexate and Disseminated Intravascular Coagulation
| Article | Year |
|---|---|
Anticoagulant Therapy for Disseminated Intravascular Coagulation After Gastrointestinal Surgery.
Topics: Anticoagulants; Digestive System Surgical Procedures; Disseminated Intravascular Coagulation; Gabexa | 2019 |
[Recent therapeutic strategy for disseminated intravascular coagulation].
Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzamidines; Disseminated Intravascular Coa | 2014 |
[Anti DIC therapy].
Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzamidines; Disseminated Intravascular Coa | 2016 |
[Treatment of DIC associated with myelogenous leukemia].
Topics: Anticoagulants; Disseminated Intravascular Coagulation; Gabexate; Heparin; Humans; Leukemia, Myeloid | 2009 |
[Treatment of disseminated intravascular coagulation].
Topics: Anticoagulants; Antithrombins; Benzamidines; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Dis | 2010 |
[Synthetic protease inhibitors for the treatment of DIC].
Topics: Anticoagulants; Arginine; Benzamidines; Disseminated Intravascular Coagulation; Gabexate; Guanidines | 2011 |
[Prevention of hemorrhage occurring in patients with leukemia].
Topics: Anticoagulants; Disseminated Intravascular Coagulation; Gabexate; Heparin; Humans; Leukemia; Platele | 2003 |
[Drug-induced disseminated intravascular coagulation (DIC)].
Topics: Animals; Anticoagulants; Antineoplastic Agents; Blood Coagulation Factors; Disseminated Intravascula | 2007 |
[Principles of the therapy for disseminated intravascular coagulation: current status and new trends].
Topics: Antifibrinolytic Agents; Antithrombin III; Blood Component Transfusion; Disseminated Intravascular C | 1993 |
[Synthetic protease inhibitors in the treatment of disseminated intravascular coagulation].
Topics: Benzamidines; Disseminated Intravascular Coagulation; Gabexate; Glycoproteins; Guanidines; Half-Life | 1993 |
[Emergency therapy of disseminated intravascular coagulation].
Topics: Anticoagulants; Blood Coagulation; Disseminated Intravascular Coagulation; Emergencies; Gabexate; He | 1995 |
Severe cutaneous and venous damage after DIC therapy.
Topics: Aged; Anticoagulants; Disseminated Intravascular Coagulation; Female; Gabexate; Humans; Necrosis; Sa | 1997 |
Disseminated intravascular coagulation in lupus erythematosus with acute liver damage.
Topics: Adult; Antithrombin III; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Gabexate | 1992 |
[Thrombosis in various diseases: disseminated intravascular coagulation and thrombosis].
Topics: Blood Coagulation; Disseminated Intravascular Coagulation; Fibrinolysis; Gabexate; Guanidines; Hepar | 1986 |
[Complement and disseminated intravascular coagulation].
Topics: Animals; Antigen-Antibody Complex; Complement Inactivator Proteins; Complement System Proteins; Dise | 1985 |
[Newborn infants and disseminated intravascular coagulation].
Topics: Bacterial Infections; Blood Coagulation Tests; Diagnosis, Differential; Disseminated Intravascular C | 1985 |
[Therapy of disseminated intravascular coagulation].
Topics: Antifibrinolytic Agents; Antithrombin III; Blood Coagulation Tests; Blood Transfusion; Disseminated | 1985 |
7 trials available for gabexate and Disseminated Intravascular Coagulation
| Article | Year |
|---|---|
A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis.
Topics: Aged; Antithrombins; Blood Coagulation; Disseminated Intravascular Coagulation; Drug Administration | 2013 |
Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombin III; Antithrombins; C-Reactive Protein; | 2012 |
Efficacy of gabexate mesilate on disseminated intravascular coagulation as a complication of infection developing after abdominal surgery.
Topics: Abdomen; Anticoagulants; APACHE; Disseminated Intravascular Coagulation; Female; Gabexate; Humans; I | 2004 |
Treatment of disseminated intravascular coagulation and its prodromal stage with gabaxate mesilate (FOY): a multi-center trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Disseminated Intravascular Coagulation; Drug Therapy, Co | 1993 |
Is protease inhibitor a choice for the treatment of pre- or mild disseminated intravascular coagulation?
Topics: Adult; Aged; Blood Coagulation Tests; Critical Care; Disseminated Intravascular Coagulation; Female; | 2000 |
Clinical evaluation of antithrombin III concentrate (BI 6.013) for disseminated intravascular coagulation in obstetrics. Well-controlled multicenter trial.
Topics: Adult; Antithrombin III; Blood Chemical Analysis; Clinical Trials as Topic; Disseminated Intravascul | 1987 |
Gabexate as a therapy for disseminated intravascular coagulation.
Topics: Anticoagulants; Clinical Trials as Topic; Disseminated Intravascular Coagulation; Gabexate; Guanidin | 1988 |
62 other studies available for gabexate and Disseminated Intravascular Coagulation
| Article | Year |
|---|---|
Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia.
Topics: Adolescent; Aged; Aged, 80 and over; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinog | 2018 |
Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies.
Topics: Adult; Anticoagulants; Benzamidines; Disseminated Intravascular Coagulation; Female; Gabexate; Guani | 2019 |
A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
Topics: Aged; Aged, 80 and over; Analysis of Variance; C-Reactive Protein; Disseminated Intravascular Coagul | 2014 |
Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Critical Care; Disseminated Intravascular Coagulatio | 2015 |
The efficacy of the administration of recombinant human soluble thrombomodulin in patients with DIC.
Topics: Adult; Aged; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; | 2016 |
[Successful treatment with the combination of recombinant human soluble thrombomodulin and gabexate mesilate in three patients with obstetric disseminated intravascular coagulation].
Topics: Abruptio Placentae; Adult; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Female | 2011 |
Thyroid storm with multiple organ failure, disseminated intravascular coagulation, and stroke with a normal serum FT3 level.
Topics: Anti-Inflammatory Agents; Anticoagulants; Antithyroid Agents; Brain Edema; Decompression, Surgical; | 2012 |
Microscopic polyangiitis associated with marked systemic bleeding tendency caused by disseminated intravascular coagulation.
Topics: Antibodies, Antineutrophil Cytoplasmic; Anticoagulants; Disseminated Intravascular Coagulation; Fata | 2003 |
[A case of severe Chlamydia pneumoniae pneumonia requiring mechanical ventilation and complicated with disseminated intravascular coagulation].
Topics: Acute Disease; Chlamydophila Infections; Chlamydophila pneumoniae; Disseminated Intravascular Coagul | 2003 |
Leukemia cutis originating in the extravasation site of i.v. gabexate mesilate infusion.
Topics: Anticoagulants; Disseminated Intravascular Coagulation; Extravasation of Diagnostic and Therapeutic | 2008 |
Application of a synthetic serine protease inhibitor in the treatment of DIC.
Topics: Animals; Chemical Phenomena; Chemistry; Disease Models, Animal; Disseminated Intravascular Coagulati | 1983 |
Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis.
Topics: Adult; Aged; Anticoagulants; Bacterial Infections; Disseminated Intravascular Coagulation; Female; G | 1983 |
Protective effect of gabexate mesilate against experimental disseminated intravascular coagulation in rats.
Topics: Animals; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen | 1983 |
The kinin-forming enzyme system in pregnancy and obstetrical DIC.
Topics: Adult; Animals; Disseminated Intravascular Coagulation; Female; Gabexate; Guanidines; Humans; Kallik | 1983 |
A histological study on microthrombi in autopsy cases of DIC.
Topics: Disseminated Intravascular Coagulation; Female; Gabexate; Guanidines; Heparin; Humans; Kidney Glomer | 1983 |
[Severe surgical infection and DIC].
Topics: Adult; Aged; Animals; Bacterial Infections; Blood Coagulation Factors; Disseminated Intravascular Co | 1983 |
[Fungal sepsis and DIC in surgical patients].
Topics: Adult; Aged; Amphotericin B; Disseminated Intravascular Coagulation; Female; Flucytosine; Gabexate; | 1983 |
[Pre- and post-operative management of Kasabach-Merritt syndrome].
Topics: Blood Coagulation; Disseminated Intravascular Coagulation; Fibrous Dysplasia of Bone; Fibrous Dyspla | 1984 |
[Disseminated intravascular coagulation (DIC) following open heart surgery and great vessel surgery. The result of early administration of gabexate mesilate (FOY)].
Topics: Adolescent; Adult; Aged; Blood Transfusion; Cardiac Surgical Procedures; Coronary Disease; Dissemina | 1984 |
Anticoagulation with a synthetic thrombin inhibitor after cardiovascular surgery and for treatment of disseminated intravascular coagulation.
Topics: Adult; Aged; Antithrombin III; Arginine; Cardiovascular Diseases; Disseminated Intravascular Coagula | 1984 |
Survival from DIC following amniotic fluid embolism. Successful treatment with a serine proteinase inhibitor; FOY.
Topics: Adult; Blood Transfusion; Disseminated Intravascular Coagulation; Embolism, Amniotic Fluid; Female; | 1981 |
[Protection of endotoxin-induced disseminated intravascular coagulation in rats by gabexate mesilate].
Topics: Animals; Disseminated Intravascular Coagulation; Endotoxins; Female; Gabexate; Guanidines; Polysacch | 1982 |
Effect of cryopreservation on the immunogenicity of pancreatic islets in xenotransplantation.
Topics: Animals; Blood Glucose; Cell Separation; Collagenases; Cryopreservation; Dimethyl Sulfoxide; Dissemi | 1994 |
[Adequate parameters for the diagnosis of disseminated intravascular coagulation (DIC) in patients with liver diseases].
Topics: Adult; Antithrombin III; Biomarkers; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinog | 1993 |
[Reactive hemophagocytic syndrome responded to combination chemotherapy with steroid pulse therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disseminated Intravascular C | 1995 |
Giant hepatic angiomyolipoma associated with disseminated intravascular coagulation.
Topics: Aged; Angiomyolipoma; Anticoagulants; Disseminated Intravascular Coagulation; Female; Fibrinolysis; | 1997 |
Pyogenic clavicular osteomyelitis associated with disseminated intravascular coagulation and acute renal failure in a patient with non-insulin-dependent diabetes mellitus.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Anticoagulants; Clavicle; Diabetes Mellitus, Type 2; Dis | 1997 |
Disseminated intravascular coagulation in a patient undergoing removal of humeral head for pain relief.
Topics: Aged; Anticoagulants; Blood Transfusion; Disseminated Intravascular Coagulation; Female; Gabexate; G | 1999 |
Calcinosis cutis and intestinal pseudoobstruction in a patient with adult onset Still's disease associated with recurrent relapses of disordered coagulopathy.
Topics: Anticoagulants; Calcinosis; Diagnosis, Differential; Disseminated Intravascular Coagulation; Drug Th | 1999 |
[A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation].
Topics: Anticoagulants; Antiparkinson Agents; Bromocriptine; Dantrolene; Disseminated Intravascular Coagulat | 1999 |
An unusual postextraction hemorrhage associated with Klippel-Trenaunay-Weber syndrome.
Topics: Adult; Anticoagulants; Dental Care for Chronically Ill; Disseminated Intravascular Coagulation; Fema | 2001 |
[Effective use of camostat mesilate for chronic disseminated intravascular coagulation complicated by thoracoabdominal aortic aneurysm].
Topics: Administration, Oral; Aged; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Chronic Disease; | 2001 |
Successful treatment of DIC with a serine proteinase inhibitor.
Topics: Aged; Disseminated Intravascular Coagulation; Gabexate; Humans; Male; Serine Proteinase Inhibitors | 2001 |
[Thoracic aortic aneurysm with chronic disseminated intravascular coagulation treated successfully with orally administered camostat mesilate, warfarin and aspirin].
Topics: Administration, Oral; Aged; Anticoagulants; Aortic Aneurysm, Thoracic; Aspirin; Chronic Disease; Dis | 2002 |
[Treatment of acute pancreatitis].
Topics: Acute Disease; Benzamidines; Disseminated Intravascular Coagulation; Drainage; Gabexate; Glycoprotei | 1992 |
[Sequential MTX and 5-FU therapy of gastric cancer with systemic bone metastasis and disseminated intravascular coagulation].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 1992 |
Disseminated carcinomatosis of bone marrow from submucosal carcinoma in adenoma of the rectum.
Topics: Adenoma; Anemia, Hemolytic; Antithrombin III; Bone Neoplasms; Carcinoma; Disseminated Intravascular | 1992 |
Use of a synthetic protease inhibitor for the treatment of L-asparaginase-induced acute pancreatitis complicated by disseminated intravascular coagulation.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benz | 1992 |
[Diagnosis and treatment of disseminated intravascular coagulation associated with neurosurgical diseases; a proposal of a new scoring system for DIC].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Diseases; Brain Injuries; Cerebrovascular Disorder | 1992 |
[Improving effect of the synthetic protease inhibitor E-3123 on experimental DIC in dogs].
Topics: Animals; Blood Coagulation Tests; Disease Models, Animal; Disseminated Intravascular Coagulation; Do | 1992 |
[Antienzyme preparations in the treatment of acute pancreatitis].
Topics: Acute Disease; Adult; Aprotinin; Benzamidines; Cytidine Diphosphate Choline; Disseminated Intravascu | 1990 |
[Protease inhibitors in shock].
Topics: Aprotinin; Disseminated Intravascular Coagulation; Gabexate; Glycoproteins; Humans; Infant, Newborn; | 1991 |
Effect of a selective PAF antagonist SM-10661 ((+/-)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one HCl) on experimental disseminated intravascular coagulation (DIC).
Topics: Administration, Oral; Animals; Disseminated Intravascular Coagulation; Endotoxins; Fibrin Fibrinogen | 1991 |
[Physiopathology and therapy of disseminated intravascular coagulation].
Topics: Antithrombin III; Disseminated Intravascular Coagulation; Gabexate; Heparin; Humans | 1991 |
[Clinical trial of protease inhibitor in the treatment of fulminant hepatitis].
Topics: Animals; Antithrombin III; Disseminated Intravascular Coagulation; Gabexate; Hepatitis; Humans; Prot | 1991 |
[Treatment of disseminated intravascular coagulation with proteinase inhibitor].
Topics: Antithrombin III; Benzamidines; Disseminated Intravascular Coagulation; Drug Therapy, Combination; F | 1991 |
[Disseminated intravascular coagulation (DIC) after artificial valve replacement: especially tricuspid regurgitation].
Topics: Adult; Aged; Anticoagulants; Disseminated Intravascular Coagulation; Female; Gabexate; Guanidines; H | 1990 |
[Evaluation of FOY therapy for DIC or pre-DIC associated with neurosurgical disease].
Topics: Anticoagulants; Disseminated Intravascular Coagulation; Drug Evaluation; Female; Fibrin Fibrinogen D | 1990 |
Disseminated intravascular coagulation after hepatic resection.
Topics: Anticoagulants; Bile Ducts; Carcinoma, Hepatocellular; Disseminated Intravascular Coagulation; Fibri | 1990 |
[Anticoagulant therapy in obstetrical disorders].
Topics: Antithrombin III; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Female; Fetal G | 1990 |
[Studies of two cases of ruptured intracranial aneurysm with disseminated intravascular coagulation].
Topics: Aged; Anticoagulants; Disseminated Intravascular Coagulation; Female; Gabexate; Guanidines; Humans; | 1989 |
Studies on the effects of primary therapy for DIC following circulatory arrest.
Topics: Animals; Anticoagulants; Benzamidines; Blood Coagulation Tests; Disseminated Intravascular Coagulati | 1986 |
[Treatment of pre-disseminated intravascular coagulation state with gabexate mesilate (FOY)].
Topics: Anticoagulants; Disseminated Intravascular Coagulation; Gabexate; Guanidines; Humans | 1986 |
A case of liver cirrhosis complicated with endotoxemia and disseminated intravascular coagulation: a case report.
Topics: Disseminated Intravascular Coagulation; Endotoxins; Female; Gabexate; Guanidines; Humans; Liver Cirr | 1987 |
Abdominal aortic aneurysm complicated with chronic disseminated intravascular coagulopathy: a case of surgical treatment.
Topics: Aged; Anticoagulants; Aorta, Abdominal; Aortic Aneurysm; Blood Vessel Prosthesis; Disseminated Intra | 1987 |
The effect of a serine proteinase inhibitor on DIC in septic abortion.
Topics: Abortion, Septic; Adult; Anticoagulants; Disseminated Intravascular Coagulation; Female; Gabexate; G | 1987 |
[Treatment of disseminated intravascular coagulation (DIC) or pre-DIC with gabexate mesilate (FOY)].
Topics: Anticoagulants; Disseminated Intravascular Coagulation; Gabexate; Guanidines; Heparin; Humans; Leuke | 1988 |
[Effects of FOY on DIC patients associated with hematological neoplastic disorders. Hanshin Cooperative Study Group of Hematological Disorders].
Topics: Aged; Aged, 80 and over; Anticoagulants; Disseminated Intravascular Coagulation; Drug Evaluation; Fe | 1987 |
Microcirculatory disturbances in endotoxin-induced disseminated intravascular coagulation. The effects of heparin and gabexate mesilate on locomotive and metabolic changes of neutrophils.
Topics: Animals; Chemotaxis, Leukocyte; Disseminated Intravascular Coagulation; Endotoxins; Free Radicals; G | 1988 |
[An analysis of disseminated intravascular coagulation by fibrinopeptides].
Topics: Adult; Aged; Blood Coagulation; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen De | 1988 |
A case of postpartum hemolytic uremic syndrome with severe elevations of liver enzymes.
Topics: Adult; Alkaline Phosphatase; Disseminated Intravascular Coagulation; Female; Furosemide; Gabexate; G | 1985 |
[Clinical study on DIC in urological malignancies].
Topics: Aged; Disseminated Intravascular Coagulation; Female; Gabexate; Guanidines; Heparin; Humans; Male; M | 1985 |